These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 29905460)

  • 1. Identification of Compounds That Decrease Glioblastoma Growth and Glucose Uptake in Vitro.
    Landis CJ; Zhang S; Benavides GA; Scott SE; Li Y; Redmann M; Tran AN; Otamias A; Darley-Usmar V; Napierala M; Zhang J; Augelli-Szafran CE; Zhang W; Hjelmeland AB
    ACS Chem Biol; 2018 Aug; 13(8):2048-2057. PubMed ID: 29905460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenotypic Screening of Chemical Libraries Enriched by Molecular Docking to Multiple Targets Selected from Glioblastoma Genomic Data.
    Xu D; Zhou D; Bum-Erdene K; Bailey BJ; Sishtla K; Liu S; Wan J; Aryal UK; Lee JA; Wells CD; Fishel ML; Corson TW; Pollok KE; Meroueh SO
    ACS Chem Biol; 2020 Jun; 15(6):1424-1444. PubMed ID: 32243127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery and Optimization of Glucose Uptake Inhibitors.
    Liu KG; Kim JI; Olszewski K; Barsotti AM; Morris K; Lamarque C; Yu X; Gaffney J; Feng XJ; Patel JP; Poyurovsky MV
    J Med Chem; 2020 May; 63(10):5201-5211. PubMed ID: 32282207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of aerobic glycolysis to decelerate tumor proliferation by small molecule inhibitors targeting glucose transporters.
    Gao M; Huang J; Jiang X; Yuan Y; Pang H; Luo S; Wang N; Yao C; Lin Z; Pu D; Zhang S; Sun P; Liu Z; Xiao Y; Wang Q; Hu Z; Yin H
    Protein Cell; 2020 Jun; 11(6):446-451. PubMed ID: 32410006
    [No Abstract]   [Full Text] [Related]  

  • 5. A molecular screening approach to identify and characterize inhibitors of glioblastoma stem cells.
    Visnyei K; Onodera H; Damoiseaux R; Saigusa K; Petrosyan S; De Vries D; Ferrari D; Saxe J; Panosyan EH; Masterman-Smith M; Mottahedeh J; Bradley KA; Huang J; Sabatti C; Nakano I; Kornblum HI
    Mol Cancer Ther; 2011 Oct; 10(10):1818-28. PubMed ID: 21859839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human glioblastoma multiforme: p53 reactivation by a novel MDM2 inhibitor.
    Costa B; Bendinelli S; Gabelloni P; Da Pozzo E; Daniele S; Scatena F; Vanacore R; Campiglia P; Bertamino A; Gomez-Monterrey I; Sorriento D; Del Giudice C; Iaccarino G; Novellino E; Martini C
    PLoS One; 2013; 8(8):e72281. PubMed ID: 23977270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A New Chalcone Derivative with Promising Antiproliferative and Anti-Invasion Activities in Glioblastoma Cells.
    Mendanha D; Vieira de Castro J; Moreira J; Costa BM; Cidade H; Pinto M; Ferreira H; Neves NM
    Molecules; 2021 Jun; 26(11):. PubMed ID: 34205043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small molecule epigenetic screen identifies novel EZH2 and HDAC inhibitors that target glioblastoma brain tumor-initiating cells.
    Grinshtein N; Rioseco CC; Marcellus R; Uehling D; Aman A; Lun X; Muto O; Podmore L; Lever J; Shen Y; Blough MD; Cairncross GJ; Robbins SM; Jones SJ; Marra MA; Al-Awar R; Senger DL; Kaplan DR
    Oncotarget; 2016 Sep; 7(37):59360-59376. PubMed ID: 27449082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitors of GLUT/SLC2A Enhance the Action of BCNU and Temozolomide against High-Grade Gliomas.
    Azzalin A; Nato G; Parmigiani E; Garello F; Buffo A; Magrassi L
    Neoplasia; 2017 Apr; 19(4):364-373. PubMed ID: 28319810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional importance of glucose transporters and chromatin epigenetic factors in Glioblastoma Multiforme (GBM): possible therapeutics.
    Chamarthy S; Mekala JR
    Metab Brain Dis; 2023 Jun; 38(5):1441-1469. PubMed ID: 37093461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Jak2 small molecule inhibitor, G6, reduces the tumorigenic potential of T98G glioblastoma cells in vitro and in vivo.
    Baskin R; Park SO; Keserű GM; Bisht KS; Wamsley HL; Sayeski PP
    PLoS One; 2014; 9(8):e105568. PubMed ID: 25162558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of novel small-molecule inhibitors of glioblastoma cell growth and invasion by high-throughput screening.
    Wang L; Zhao H; Cui K; Yao L; Ren M; Hao A; Smollen P; Nie F; Jin G; Liu Q; Wong ST
    Biosci Trends; 2012 Aug; 6(4):192-200. PubMed ID: 23006966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-SEMA3A Antibody: A Novel Therapeutic Agent to Suppress Glioblastoma Tumor Growth.
    Lee J; Shin YJ; Lee K; Cho HJ; Sa JK; Lee SY; Kim SH; Lee J; Yoon Y; Nam DH
    Cancer Res Treat; 2018 Jul; 50(3):1009-1022. PubMed ID: 29129044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and characterization of a small-molecule inhibitor of Wnt signaling in glioblastoma cells.
    De Robertis A; Valensin S; Rossi M; Tunici P; Verani M; De Rosa A; Giordano C; Varrone M; Nencini A; Pratelli C; Benicchi T; Bakker A; Hill J; Sangthongpitag K; Pendharkar V; Liu B; Ng FM; Then SW; Jing Tai S; Cheong SM; He X; Caricasole A; Salerno M
    Mol Cancer Ther; 2013 Jul; 12(7):1180-9. PubMed ID: 23619303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pre-Clinical Drug Testing in 2D and 3D Human In Vitro Models of Glioblastoma Incorporating Non-Neoplastic Astrocytes: Tunneling Nano Tubules and Mitochondrial Transfer Modulates Cell Behavior and Therapeutic Respons.
    Civita P; M Leite D; Pilkington GJ
    Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31795330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a Small-Molecule Glucose Transporter Inhibitor, Glutipyran, That Inhibits Cancer Cell Growth.
    Kawatani M; Aono H; Hiranuma S; Shimizu T; Muroi M; Ogawa N; Ohishi T; Ohba SI; Kawada M; Nogawa T; Okano A; Hashizume D; Osada H
    ACS Chem Biol; 2021 Aug; 16(8):1576-1586. PubMed ID: 34296611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N6-isopentenyladenosine inhibits aerobic glycolysis in glioblastoma cells by targeting PKM2 expression and activity.
    Pagano C; Coppola L; Navarra G; Avilia G; Savarese B; Torelli G; Bruzzaniti S; Piemonte E; Galgani M; Laezza C; Bifulco M
    FEBS Open Bio; 2024 May; 14(5):843-854. PubMed ID: 38514913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis and biological evaluation of novel 1,3,4-thiadiazole derivatives as anti-glioblastoma agents targeting the AKT pathway.
    Szeliga M; Karpińska M; Rola R; Niewiadomy A
    Bioorg Chem; 2020 Dec; 105():104362. PubMed ID: 33074121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucose-6-phosphatase is a key metabolic regulator of glioblastoma invasion.
    Abbadi S; Rodarte JJ; Abutaleb A; Lavell E; Smith CL; Ruff W; Schiller J; Olivi A; Levchenko A; Guerrero-Cazares H; Quinones-Hinojosa A
    Mol Cancer Res; 2014 Nov; 12(11):1547-59. PubMed ID: 25001192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-capacity glycolytic and mitochondrial oxidative metabolisms mediate the growth ability of glioblastoma.
    Kim J; Han J; Jang Y; Kim SJ; Lee MJ; Ryu MJ; Kweon GR; Heo JY
    Int J Oncol; 2015 Sep; 47(3):1009-16. PubMed ID: 26202438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.